High mobility group box 1 pseudogene 39 (HMGB1P39)

HMGB1P39 is a processed pseudogene located in the human genome and is related to the high mobility group box 1 (HMGB1) and possibly high mobility group box 2 (HMGB2) genes, which encode chromatin-associated proteins involved in DNA binding, bending, and regulation of gene expression. Pseudogenes such as HMGB1P39 do not encode functional proteins due to sequence defects or lack of transcription and are generally not considered therapeutic targets. However, some pseudogenes, when transcribed, can regulate their parent genes by acting as competitive endogenous RNAs (ceRNAs) or by providing substrates for regulatory small RNAs[2][4][8]. There is no publicly available evidence that HMGB1P39 encodes a protein or acts as a direct therapeutic target, nor is there disease association or drug interaction data specific to HMGB1P39. Key clarification: HMGB1P39 is not a protein-coding gene and is not recognized as a validated therapeutic target. The main functional HMGB proteins—such as High mobility group box 1 (HMGB1)—are biologically active and involved in chromatin dynamics, immune regulation, and disease processes, but the pseudogene HMGB1P39 does not share these functional roles[1][3][5][7]. Note on possible error: The query conflates the biologically active HMGB1/HMGB2 proteins with the pseudogene HMGB1P39. Pseudogenes by definition usually lack protein-coding capacity and direct therapeutic relevance unless shown to have a regulatory RNA function, which is not established for HMGB1P39. Therefore, *is_incorrect* is marked as true for "therapeutic target" classification in this context.

Other names

High-mobility group box 2 pseudogeneHMGB2 pseudogeneHMGB1 pseudogene 39HMGB1P39